Top 50 MeSH Terms
Humans                             :   96 (96.0%)
Animals                            :   64 (64.0%)
Amyloid beta-Peptides/metabolism   :   20 (20.0%)
Mice                               :   10 (10.0%)
Brain/metabolism                   :   10 (10.0%)
Molecular Targeted Therapy         :    8 ( 8.0%)
Aged                               :    7 ( 7.0%)
Genome-Wide Association Study      :    7 ( 7.0%)
Male                               :    6 ( 6.0%)
Blood-Brain Barrier/metabolism     :    6 ( 6.0%)
Drug Delivery Systems              :    6 ( 6.0%)
*Neurodegenerative Diseases        :    6 ( 6.0%)
Drug Delivery Systems/methods      :    6 ( 6.0%)
*Drug Delivery Systems/methods     :    5 ( 5.0%)
*Alzheimer Disease/drug therapy/genetics:    5 ( 5.0%)
tau Proteins/metabolism            :    5 ( 5.0%)
Disease Models, Animal             :    5 ( 5.0%)
*Alzheimer Disease/drug therapy/metabolism:    4 ( 4.0%)
Mice, Transgenic                   :    4 ( 4.0%)
Female                             :    4 ( 4.0%)
Mitochondria/metabolism            :    4 ( 4.0%)
*Immunotherapy/methods             :    4 ( 4.0%)
Biomarkers                         :    4 ( 4.0%)
Nanoparticles/chemistry            :    4 ( 4.0%)
*Molecular Targeted Therapy        :    4 ( 4.0%)
Amyloid/metabolism                 :    3 ( 3.0%)
Signal Transduction                :    3 ( 3.0%)
Alzheimer Disease/drug therapy     :    3 ( 3.0%)
*Neurodegenerative Diseases/drug therapy:    3 ( 3.0%)
Amyloid beta-Peptides              :    3 ( 3.0%)
Plaque, Amyloid/pathology          :    3 ( 3.0%)
Mendelian Randomization Analysis   :    3 ( 3.0%)
*Alzheimer Disease/genetics        :    3 ( 3.0%)
*tau Proteins/metabolism           :    3 ( 3.0%)
*Neurons/metabolism                :    2 ( 2.0%)
Protein Aggregation, Pathological/metabolism:    2 ( 2.0%)
*Blood-Brain Barrier/metabolism/drug effects:    2 ( 2.0%)
Biological Transport               :    2 ( 2.0%)
Amyloid beta-Peptides/*metabolism  :    2 ( 2.0%)
Amyloid beta-Protein Precursor/metabolism:    2 ( 2.0%)
*Brain/metabolism                  :    2 ( 2.0%)
Immunotherapy/methods              :    2 ( 2.0%)
Alzheimer Disease/*drug therapy/*metabolism:    2 ( 2.0%)
*Nanoparticles/therapeutic use     :    2 ( 2.0%)
Amyloid Precursor Protein Secretases/metabolism:    2 ( 2.0%)
Disease Susceptibility             :    2 ( 2.0%)
Blood-Brain Barrier                :    2 ( 2.0%)
*Alzheimer Disease/metabolism      :    2 ( 2.0%)
Oxidative Stress                   :    2 ( 2.0%)
Mitophagy                          :    2 ( 2.0%)

MeSH Categories
Diagnosis           :   19
Drug Therapy        :  209
Genetics            :   65
Pathology           :  104
Clinical            :    4
Molecular           :   20
Risk Factors        :   17